Ipsen to buy some Merrimack assets for about $1 billion
Jan 8 (Reuters) - French drugmaker Ipsen SA said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc, including its pancreatic cancer treatment Onivyde, for about $1 billion. [Source]
Publication Date:Origin: reuters.com
Category: mergersNews
Topics: billion, assets, Ipsen, Onivyde, cancer treatment, pancreatic, including, Merrimack Pharmaceuticals, would, on Monday, drugmaker, French, (Reuters), Merrimack